1. Home
  2. ALG vs TVTX Comparison

ALG vs TVTX Comparison

Compare ALG & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALG
  • TVTX
  • Stock Information
  • Founded
  • ALG 1955
  • TVTX 2008
  • Country
  • ALG United States
  • TVTX United States
  • Employees
  • ALG N/A
  • TVTX N/A
  • Industry
  • ALG Industrial Machinery/Components
  • TVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALG Industrials
  • TVTX Health Care
  • Exchange
  • ALG Nasdaq
  • TVTX Nasdaq
  • Market Cap
  • ALG 1.9B
  • TVTX 1.7B
  • IPO Year
  • ALG 1993
  • TVTX N/A
  • Fundamental
  • Price
  • ALG $191.50
  • TVTX $20.02
  • Analyst Decision
  • ALG Strong Buy
  • TVTX Strong Buy
  • Analyst Count
  • ALG 3
  • TVTX 14
  • Target Price
  • ALG $214.00
  • TVTX $33.31
  • AVG Volume (30 Days)
  • ALG 90.6K
  • TVTX 1.5M
  • Earning Date
  • ALG 05-08-2025
  • TVTX 05-01-2025
  • Dividend Yield
  • ALG 0.63%
  • TVTX N/A
  • EPS Growth
  • ALG N/A
  • TVTX N/A
  • EPS
  • ALG 9.60
  • TVTX N/A
  • Revenue
  • ALG $1,593,877,000.00
  • TVTX $273,533,000.00
  • Revenue This Year
  • ALG $0.40
  • TVTX $68.31
  • Revenue Next Year
  • ALG $3.79
  • TVTX $55.65
  • P/E Ratio
  • ALG $19.71
  • TVTX N/A
  • Revenue Growth
  • ALG N/A
  • TVTX 75.65
  • 52 Week Low
  • ALG $157.07
  • TVTX $6.01
  • 52 Week High
  • ALG $205.62
  • TVTX $25.29
  • Technical
  • Relative Strength Index (RSI)
  • ALG 70.07
  • TVTX 58.32
  • Support Level
  • ALG $170.95
  • TVTX $19.65
  • Resistance Level
  • ALG $175.73
  • TVTX $22.07
  • Average True Range (ATR)
  • ALG 4.57
  • TVTX 1.11
  • MACD
  • ALG 2.47
  • TVTX 0.31
  • Stochastic Oscillator
  • ALG 100.00
  • TVTX 69.58

About ALG Alamo Group Inc.

Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial and agricultural use. Its products include tractor-mounted and self-propelled mowers, zero-turn mowers, agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, and snow removal equipment. The company's reportable segments are Vegetation Management and Industrial Equipment. It generates a majority of revenue from Vegetation Management. Geographically, it generates the majority of revenue from United States.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: